Comparison between Brooks Laboratories IPO and Tijaria Polypipes IPO.
Brooks Laboratories IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Tijaria Polypipes IPO is a Mainboard Fixed Price proposed to list at BSE, NSE.
The total issue size of Brooks Laboratories IPO is up to ₹63.00 Cr whereas the issue size of the Tijaria Polypipes IPO is up to ₹60.00 Cr. The final issue price of Brooks Laboratories IPO is ₹100.00 per share and of Tijaria Polypipes IPO is ₹60.00 per share.
| Brooks Laboratories IPO | Tijaria Polypipes IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹90.00 per share | |
| Issue Price (Upper) | ₹100.00 per share | |
| Issue Price (Final) | ₹100.00 per share | ₹60.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 60 shares | 100 shares |
| Fresh Issue Size | 63,00,000 shares | 1,00,00,407 shares |
| Fresh Issue Size (Amount) | up to ₹63.00 Cr | up to ₹60.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 63,00,000 shares | 1,00,00,407 shares |
| Issue Size Total (Amount) | up to ₹63.00 Cr | up to ₹60.00 Cr |
Brooks Laboratories IPO opens on Aug 16, 2011, while Tijaria Polypipes IPO opens on Sep 27, 2011. The closing date of Brooks Laboratories IPO and Tijaria Polypipes IPO is Aug 18, 2011, and Sep 29, 2011, respectively.
| Brooks Laboratories IPO | Tijaria Polypipes IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 16, 2011 | Sep 27, 2011 |
| Issue Close | Aug 18, 2011 | Sep 29, 2011 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 05, 2011 | Oct 14, 2011 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Brooks Laboratories IPO P/E ratio is , as compared to Tijaria Polypipes IPO P/E ratio of .
| Brooks Laboratories IPO | Tijaria Polypipes IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.5 | 1 | ||||
| Promoter Shareholding (Post-Issue) | 60.77 | 57.67 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹161.86 Cr. | ₹141.76 Cr. | ||||
| ROE | ||||||
| ROCE | 27.3 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 47.4 | 19.47 |
In the Brooks Laboratories IPO Retail Individual Investors (RII) are offered 22,05,000 shares while in Tijaria Polypipes IPO retail investors are offered 22,05,000 shares. Qualified Institutional Buyers (QIB) are offered 31,50,000 shares in Brooks Laboratories IPO and in Tijaria Polypipes IPO.
| Brooks Laboratories IPO | Tijaria Polypipes IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 31,50,000 shares | |
| NII | 9,45,000 shares | 50,00,000 shares |
| RII | 22,05,000 shares | 50,00,000 shares |
| Employee | ||
| Others | ||
| Total | 63,00,000 shares | 1,00,00,000 shares |
Brooks Laboratories IPO subscribed 1.60x in total, whereas Tijaria Polypipes IPO subscribed 1.20x.
| Brooks Laboratories IPO | Tijaria Polypipes IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.82x | 0.68x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.36x | 1.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.60x | 1.20x |
